Your browser doesn't support javascript.
loading
Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals.
Goh, Yun Shan; Rouers, Angeline; Fong, Siew-Wai; Zhuo, Nicole Ziyi; Hor, Pei Xiang; Loh, Chiew Yee; Huang, Yuling; Neo, Vanessa Kexin; Kam, Isaac Kai Jie; Wang, Bei; Ngoh, Eve Zi Xian; Salleh, Siti Nazihah Mohd; Lee, Raphael Tze Chuen; Pada, Surinder; Sun, Louisa Jin; Ong, Desmond Luan Seng; Somani, Jyoti; Lee, Eng Sing; Maurer-Stroh, Sebastian; Wang, Cheng-I; Leo, Yee-Sin; Ren, Ee Chee; Lye, David C; Young, Barnaby Edward; Ng, Lisa F P; Renia, Laurent.
Afiliação
  • Goh YS; ASTAR Infectious Diseases Labs (ASTAR ID Labs), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.
  • Rouers A; ASTAR Infectious Diseases Labs (ASTAR ID Labs), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.
  • Fong SW; ASTAR Infectious Diseases Labs (ASTAR ID Labs), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.
  • Zhuo NZ; Singapore Immunology Network, Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.
  • Hor PX; ASTAR Infectious Diseases Labs (ASTAR ID Labs), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.
  • Loh CY; ASTAR Infectious Diseases Labs (ASTAR ID Labs), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.
  • Huang Y; ASTAR Infectious Diseases Labs (ASTAR ID Labs), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.
  • Neo VK; ASTAR Infectious Diseases Labs (ASTAR ID Labs), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.
  • Kam IKJ; ASTAR Infectious Diseases Labs (ASTAR ID Labs), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.
  • Wang B; Singapore Immunology Network, Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.
  • Ngoh EZX; Singapore Immunology Network, Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.
  • Salleh SNM; Singapore Immunology Network, Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.
  • Lee RTC; Bioinformatics Institute, Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.
  • Pada S; Global Data Science Initiative (GISAID), Munich, Germany.
  • Sun LJ; Infectious Diseases, Ng Teng Fong General Hospital, Singapore, Singapore.
  • Ong DLS; Infectious Diseases, Alexandra Hospital, Singapore, Singapore.
  • Somani J; National University Polyclinic, Singapore, Singapore.
  • Lee ES; Division of Infectious Diseases, Department of Medicine, National University Hospital, National University Health System, Singapore, Singapore.
  • Leo YS; ASTAR Infectious Diseases Labs (ASTAR ID Labs), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.
  • Ren EC; Bioinformatics Institute, Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.
  • Lye DC; Global Data Science Initiative (GISAID), Munich, Germany.
  • Young BE; National Public Health Laboratory, National Centre for Infectious Diseases (NCID), Singapore, Singapore.
  • Ng LFP; Department of Biological Sciences, National University of Singapore, Singapore, Singapore.
  • Renia L; Singapore Immunology Network, Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.
Front Immunol ; 13: 1031852, 2022.
Article em En | MEDLINE | ID: mdl-36451833
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Aged / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Prognostic_studies Limite: Aged / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article